Found 222 clinical trials
Lupus Research Study
This study is taking place at our Clearwater, FL office. It is for patients diagnosed with mild to moderate and moderate to severe lupus.
- 25 views
- 23 Nov, 2020
- 1 location
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
- 960 views
- 25 Mar, 2021
- 2 locations
A Phase 2 Study to Investigate the Safety and Efficacy of ABBV-105 and Upadacitinib Given Alone or in Combination (ABBV-599 Combination) in Subjects with Moderately to Severely Active Systemic Lupus Erythematosus
, tolerable, and effective in treating your moderately to severely active systemic lupus erythematosus (SLE).
- 61 views
- 23 Nov, 2020
- 1 location
Do you suffer from lupus?
Do you suffer from lupus? If so, you may qualify for a clinical trial at Wake Research testing an investigational medication designed for this condition.
- 122 views
- 18 May, 2020
- 1 location
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Multicenter, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Investigational Product in Patients With Systemic Lupus Erythematosus
- 674 views
- 08 Nov, 2020
- 1 location
A research study in subjects with Systemic Lupus Erythematosus to evaluate the clinical activity of an investigational medication.
A research study in subjects with Systemic Lupus Erythematosus to evaluate the clinical activity of an investigational medication.
- 426 views
- 23 Nov, 2020
- 1 location
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
LILAC Study For Patients with Cutaneous and/or Systemic Lupus
- 340 views
- 25 Mar, 2021
- 6 locations
Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)
Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)
- 926 views
- 25 Mar, 2021
- 12 locations
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Study Of The Efficacy And Safety Of tofacitinib In Subjects With Active Ankylosing Spondylitis (AS).
- 171 views
- 23 Nov, 2020
- 1 location
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Safety and Efficacy of CCX168 (Avacopan) in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis Treated Concomitantly with Rituximab or Cyclophosphamide/Azathioprine
- 346 views
- 25 Mar, 2021
- 1 location